Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2007
12/06/2007CA2653771A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
12/06/2007CA2653769A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/06/2007CA2653681A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use
12/06/2007CA2653675A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydroimidazopyridine and tetrahydrotriazolopyridine derivatives and their use
12/06/2007CA2653672A1 Dihydro-pyrrolopyridine, dihydro-pyrrolopyridazine and dihydro-pyrrolopyrimidine derivatives and their use
12/06/2007CA2653662A1 Spirocyclic nitriles as protease inhibitors
12/06/2007CA2653529A1 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/06/2007CA2653460A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
12/06/2007CA2653412A1 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
12/06/2007CA2653371A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
12/06/2007CA2652501A1 Novel heterocyclic compound or salt thereof and intermediate thereof
12/06/2007CA2651857A1 Aryl-4-ethynyl-isoxazole derivatives
12/06/2007CA2651849A1 Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
12/06/2007CA2651454A1 Imidazoazephinone compounds
12/05/2007EP1861403A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
12/05/2007EP1861401A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
12/05/2007EP1861400A1 Crystal forms of an imidazole derivative
12/05/2007EP1861399A2 Cgrp receptor antagonists
12/05/2007EP1861397A2 Production of dolasetron
12/05/2007EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/05/2007EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands
12/05/2007EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
12/05/2007EP1861095A1 Derivatives of imidazo(1,2-a)pyridine useful as medicaments for treating gastrointestinal diseases
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/05/2007CN101084217A Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
12/05/2007CN101081853A 7-phenylpyrazolopyridine compounds
12/05/2007CN101081851A Preparation method of alpha-aza toroid drug template
12/05/2007CN101081850A 7-phenylpyrazolopyridine compounds
12/05/2007CN101081845A Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders
12/05/2007CN100352816C Nociceptin analogs
12/05/2007CN100352807C Chemical compounds
12/04/2007US7304158 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304074 Aminoimidazlinones and aminothiazolinones: 6-[2-(2,4-Bis-trifluoromethyl-benzylamino)-5-oxo-3,5-dihydro-imidazol-4-ylidenemethyl]-4-isopropoxy-[1,5]naphthyridine-3-carbonitrile; inhibit cyclin-dependent kinase 1 and are selective against Cdk2 and Cdk4; control of breast, lung, colon and prostate tumors
12/04/2007US7304072 Spiro compounds
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007US7304050 Antibacterial agents
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
11/2007
11/29/2007WO2007136197A1 Ring-fused lactam derivatives with diexomethylene groups and preparation method thereof
11/29/2007WO2007136085A1 Spiro tetracyclic compound
11/29/2007WO2007135970A1 Heterocyclic type cinnamide derivative
11/29/2007WO2007135890A1 Novel compound having affinity for amyloid
11/29/2007WO2007135398A1 Indole derivatives
11/29/2007WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007135122A1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
11/29/2007WO2007135120A1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
11/29/2007WO2007115409A8 Compositions and methods for modulating gated ion channels
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007WO2007076320A3 Compounds
11/29/2007WO2007075895A3 Heterocyclic derivatives as modulators of ion channels
11/29/2007WO2007075869A3 Bicyclic heteroaryl compounds
11/29/2007US20070276016 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety
11/29/2007US20070276003 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
11/29/2007US20070275995 Thiobenzimidazole derivatives
11/29/2007US20070275994 Novel Antinfective Compounds
11/29/2007US20070275990 Heterocyclic Spiro Compound
11/29/2007US20070275975 3-quinuclidinyl amino-substituted biaryl derivatives
11/29/2007US20070275973 Aryl fused azapolycyclic compounds
11/29/2007US20070275972 Pyridopyrazines and the use thereof as kinase inhibitors
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275964 Cannabinoid receptor ligands and uses thereof
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007CA2653783A1 Novel compound having affinity for amyloid
11/29/2007CA2652758A1 Reversion of malignant phenotype with 9-hydroxy ellipticine derivatives
11/29/2007CA2652484A1 Heterocyclic type cinnamide derivative
11/29/2007CA2651420A1 Spiro tetracyclic compound
11/29/2007CA2650611A1 Compositions and methods for fgf receptor kinases inhibitors
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858869A1 Acylated piperidines as glycine transporter inhibitors
11/28/2007EP1858513A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
11/28/2007EP1737862A4 Imidazopyridine compound
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1678177B1 Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
11/28/2007EP1458395B1 Medical use of gsk3-inhibiting oxindole derivatives
11/28/2007CN101080407A Crystalline forms of a factor XA inhibitor
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080394A Heterocyclical chromophore architectures
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN100351254C Bisphenols monomer with imide structure and its synthesis
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/27/2007US7301027 Process for the preparation of Imiquimod and intermediates thereof
11/27/2007US7301012 Azo dye, image-forming coloring composition, ink for ink jet recording, heat-sensitive recording material, color toner and color filter
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300944 Alzheimer's disease, bipolar disorder, diabetes, dementia, stroke, schizophrenia, depression, hair loss, cancer
11/27/2007US7300943 Pyrazolo[3,4-b]pyridin-6-ones which are inhibitors of cyclin-dependent protein kinases and glycogen synthase kinase; diabetes, dementia, Alzheimer's disease, stroke, schizophrenia, alopecia, and cancer; antiasthmatics, angiogenesis inhibitors; antiproliferative, neuroprotective and neuroleptic agents
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300732 Organophotoreceptors with azine-based compounds
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007WO2007134085A2 Isothiazolidines useful in the treatment of ocular hypertensive conditions
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 646